Onxol
Onxol (paclitaxel) is an antineoplastic (chemotherapy) medication classified as a taxane. It works by stabilizing microtubules and preventing their disassembly, which effectively blocks cell division (mitosis) and leads to cancer cell death.
Dosage by Body Weight
Administered strictly via intravenous (IV) infusion under the supervision of a qualified oncologist. Dosage is highly individualized and typically calculated based on Body Surface Area (BSA, mg/m²) rather than body weight. Patients must be premedicated with corticosteroids, antihistamines, and H2 antagonists to prevent severe hypersensitivity reactions.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist.
- Body Weight
- 5-7 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist.
- Body Weight
- 8-10 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist.
- Body Weight
- 11-15 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist.
- Body Weight
- 16-20 kg
- Dose
- Not routine
- Frequency
- Not applicable
- Tracking Notes
- Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Not applicable | Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist. |
| 5-7 kg | Not routine | Not applicable | Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist. |
| 8-10 kg | Not routine | Not applicable | Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist. |
| 11-15 kg | Not routine | Not applicable | Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist. |
| 16-20 kg | Not routine | Not applicable | Chemotherapeutic agents like paclitaxel are not routinely dosed for pediatric patients in this weight range, and dosing must be strictly calculated using Body Surface Area (BSA) by a pediatric oncologist. |
Formulation
Purpose
Treatment of advanced ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), and AIDS-related Kaposi's sarcoma.
Generic Name
PaclitaxelScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.